Dr. Jose David Herazo-Maya, MD

Dr. Herazo-Maya practices at Tampa General Hospital in Tampa, Florida, part of Tampa General Hospital.

Dr. Herazo-Maya's NPI, 1164684353, was assigned on June 28, 2008. Dr. Herazo-Maya graduated from Universidad de Cartegena in 2003. Dr. Herazo-Maya holds Florida license ME129944.

Dr. Herazo-Maya's primary practice is Tampa General Hospital, at 1 Tampa General Cir, Tampa, FL 33606 in Hillsborough County. The practice phone is (813) 844-7000.

Dr. Herazo-Maya's primary practice is Tampa General Hospital in Tampa, Florida, part of Tampa General Hospital. Dr. Herazo-Maya is also affiliated with BayCare St. Joseph's Hospital. The medical group on file is USF Therapy Services. Dmand AI also links Dr. Herazo-Maya to 3 more hospitals and 1 skilled nursing facility, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Herazo-Maya practices, 6 sites in all. Vendor and product names are available with a free account.

Pulmonary disease is Dr. Herazo-Maya's primary specialty in the NPI Registry, under taxonomy code 207RP1001X. Dr. Herazo-Maya is board certified in critical care medicine by the American Board of Internal Medicine. Dmand AI has Dr. Herazo-Maya's licenses on file in 3 states: Florida, Connecticut and Pennsylvania.

Dmand AI lists chronic lung disease, pulmonary fibrosis and pulmonary heart disease among the conditions Dr. Herazo-Maya treats.

CMS data shows 285 Medicare services from Dr. Herazo-Maya across 4 procedure codes in 2024, for 202 Medicare patients. Medicare paid $35,022 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 202 Medicare patients who saw Dr. Herazo-Maya in 2024. The largest group is 65 to 74, with 95 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 13% are also on Medicaid. Their average risk score is 2.87, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Herazo-Maya's median patient age at 68, with 54% women.

In 2024, Dr. Herazo-Maya wrote 623 Medicare Part D claims for 139 patients. 54% of them were for generic drugs. CMS names the drug for 475 of them, across 9 drugs with 11 or more claims each, at $2,709,314 in total drug cost. In 2023, CMS named 319 claims across 9 drugs.

Dr. Herazo-Maya accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 37 papers to Dr. Herazo-Maya, published from 2014 to 2025. 2017 was the busiest year, with 6. The most frequent topics are Idiopathic Pulmonary Fibrosis, Lung and Disease Progression. Dr. Herazo-Maya has published most often in Am J Respir Crit Care Med. Dr. Herazo-Maya's most frequent co-authors are Brenda Maria Juan-Guardela, MD, Debabrata Bandyopadhyay, MD and Mridu Gulati, MD.

CMS Open Payments shows 64 general payments to Dr. Herazo-Maya from 13 drug and device companies from 2017 to 2025. Food and beverage make up the largest share, 35% of the total. Boehringer Ingelheim Pharmaceuticals, Inc. paid the most, $7,879.

Dr. Herazo-Maya graduated from Universidad de Cartegena in 2003.

Dr. Herazo-Maya is in network with 12 carriers, including Aetna, Excellus BlueCross BlueShield and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 11. Check the plan with the practice before a visit.